endocrine/exocrine glands
| N |
• mice exhibit normal mammary gland development
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Tg(S100a4-cre)1Gle transgene insertion 1, Gustavo Leone MGI:3775823 |
||||||||||||||||||||||||
| Summary |
5 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• mice exhibit normal mammary gland development
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• fewer mammary tumors form than in Ets2tm1Rgo/Ets2tm5.1Rgo Tg(MMTV-PyVT)634Mul mice and progression to adenoma and early carcinoma is slowed
|
|
• fewer mammary tumors form than in Ets2tm1Rgo/Ets2tm5.1Rgo Tg(MMTV-PyVT)634Mul mice and progression to adenoma and early carcinoma is slowed
|
|
• fewer mammary tumors form than in Ets2tm1Rgo/Ets2tm5.1Rgo Tg(MMTV-PyVT)634Mul mice and progression to adenoma and early carcinoma is slowed
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• fewer and smaller tumors form in mice injected with the mammary tumor line NT2.5 compared to in similarly treated Ptentm1.1Mwst/Ptentm1.1Mwst Tg(S100a4-cre)1Gle mice
|
|
• mice injected with the mammary tumor line NT2.5 develop more mammary tumors than in similarly treated Ptentm1.1Mwst homozygotes
|
|
• mammary tumors induced by NT2.5 exhibit decreased numbers of macrophages and recruitment of new vasculature compared to in similarly treated Ptentm1.1Mwst homozygotes
|
|
• fewer and smaller tumors form in mice injected with the mammary tumor line NT2.5 compared to in similarly treated Ptentm1.1Mwst/Ptentm1.1Mwst Tg(S100a4-cre)1Gle mice
|
|
• mice injected with the mammary tumor line NT2.5 develop more mammary tumors than in similarly treated Ptentm1.1Mwst homozygotes
|
|
• fewer and smaller tumors form in mice injected with the mammary tumor line NT2.5 compared to in similarly treated Ptentm1.1Mwst/Ptentm1.1Mwst Tg(S100a4-cre)1Gle mice
|
|
• mice injected with the mammary tumor line NT2.5 develop more mammary tumors than in similarly treated Ptentm1.1Mwst homozygotes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mice injected with the mammary tumor line NT2.5 develop more mammary tumors than in similarly treated Ptentm1.1Mwst homozygotes
|
|
• mice injected with the mammary tumor line NT2.5 develop more mammary tumors than in similarly treated Ptentm1.1Mwst homozygotes
|
|
• mice injected with the mammary tumor line NT2.5 develop more mammary tumors than in similarly treated Ptentm1.1Mwst homozygotes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mesenchymal cells transplanted into wild-type mice induce more mammary tumors that similarly treated Ptentm1.1Mwst/Ptentm1.1Mwst Tg(MMTVneu)202Mul cells
• mammary tumors progress to adenoma, carcinoma in situ, and invasive carcinoma
|
|
• mesenchymal cells transplanted into wild-type mice induce more mammary tumors that similarly treated Ptentm1.1Mwst/Ptentm1.1Mwst Tg(MMTVneu)202Mul cells
• mammary tumors progress to adenoma, carcinoma in situ, and invasive carcinoma
|
|
• mesenchymal cells transplanted into wild-type mice induce more mammary tumors that similarly treated Ptentm1.1Mwst/Ptentm1.1Mwst Tg(MMTVneu)202Mul cells
• mammary tumors progress to adenoma, carcinoma in situ, and invasive carcinoma
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/20/2026 MGI 6.24 |
|
|
|
||


